Dr. Richard Katz, MD, MHA, is a strategic leader in the pharmaceutical and medical technology industries, specializing in CNS disorders, regenerative medicine, and evidence generation in drug development. Consulting within the medical technology and life sciences sectors, he focuses on developing cutting-edge, affordable treatments. He has expertise in NBME exam development and emerging fields like regenerative medicine, and demonstrates a passion for advancing medical education.